Josh4580 Posted March 5, 2015 Share Posted March 5, 2015 Started buying this stock at $2.50 with an average price around $3. Up around 35% today to $3.78. Barrons article today basically sums up my whole thesis so here is the link: http://online.barrons.com/news/articles/SB51367578116875004693704580500021807004844?mod=yahoobarrons&ru=yahoo Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1989673 Standard of care right now for MF is Jakafi which only addresses the side-effects and doesn't put the cancer into remission. Imetelstat actually puts the disease into remission. Jakafi is owned by Incyte, which has a market cap of $15.80 billion, mainly from this drug. Geron's market cap is $594 million. Thoughts? Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now